Screener
Viridian Therapeutics, Inc. VRDN Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, series A non-voting convertible preferred stock, $0.01 par value; 435,000 shares authorized; 133,191 and 134,864 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 60,432 | 61,188 |
| Preferred stock, series B non-voting convertible preferred stock, $0.01 par value; 500,000 shares authorized; 48,463 and 79,620 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 37,592 | 70,868 |
| Common stock, $0.01 par value; 200,000,000 shares authorized; 113,238,218 and 101,826,500 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 1,132 | 1,018 |
| Additional paid-in capital | 2,134,572 | 1,927,104 |
| Accumulated other comprehensive income (loss) | (1,153) | 447 |
| Accumulated deficit | (1,570,478) | (1,338,458) |
| Total stockholders’ equity | 662,097 | 722,167 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Viridian Therapeutics, Inc. (VRDN) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
- How has Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
- What does common stock, par value (in dollars per share) mean?
- Common stock, par value (in dollars per share)
Ask your AI about Viridian Therapeutics, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude